The Supreme Council of Health (SCH) has issued a circular to all pharmacies in Qatar to withdraw batch number (N066) and (N143) of Panadol 100ml syrup for children and babies.
The Pharmacy Management and Drug Control Department of SCH explained that an error was detected in the printing of the dosage information on the outer packaging by the manufacturer of the medicine, GlaxoSmithKline.
The administration has assured the public that there is no defect in the property and that the quality of the rest of the batches of the medicine currently available in the country is safe for use.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Heavy rains all over Qatar, residents advised caution
Amir hails Kuwait’s support for IPU session
Pakistan prime minister meets FM
Qatar, Malaysia for more
UN praises Qatar’s swift Gaza aid response
Al Shaqab horses land four gold medals in Morocco
Al Khalij holds seminar on breast cancer screening
HMC, Glasgow University to study anti-smoking campaigns’ effectiveness
Doha Port to host 42 cruise ships this season